-
Danaher Corporation Launches Western Innovation Center in Chongqing
•
Danaher Corporation (NYSE: DHR), a leading science and technology services provider based in the U.S., has inaugurated the first phase of its Danaher Western Innovation Center in the Chongqing Liang Jiang New Area. The new facility, situated in proximity to the Children’s Hospital of Chongqing Medical University, is designed to…
-
Danaher Corporation Partners with Chongqing Liang Jiang New Area to Establish Western Innovation Center
•
Danaher Corporation (NYSE: DHR), a leading science and technology services provider in the U.S., has entered into a partnership with the Chongqing Liang Jiang New Area government to establish the Danaher Western Innovation Center in the district. This new center, located adjacent to the Children’s Hospital of Chongqing Medical University,…
-
Danaher Corporation to Establish Northern China Headquarters in Beijing’s Changping District
•
The Changping District People’s Government of Beijing Municipality has entered into a strategic cooperation agreement with Danaher Corporation (NYSE: DHR), a leading science and technology services provider based in the United States. The agreement encompasses the establishment of Danaher’s northern China headquarters in the district, along with the development of…
-
Danaher Corporation Partners with CHEA to Boost Oncology Centers in Chinese Counties
•
US-based science and technology services giant Danaher Corporation (NYSE: DHR) has entered into a partnership with the hospital management unit of the China Health Economics Association (CHEA). The collaboration aims to promote the development of oncology prevention and control centers at the county hospital level in China, with no financial…
-
CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&J, BeiGene, and Fosun Pharma Announce China Partnerships
•
The 6th China International Import Expo (CIIE) held in Shanghai this week has been a platform for multiple companies to announce their strategic partnerships in China. Among the notable participants are Danaher (NYSE: DHR), Boehringer-Ingelheim (BI), Merck Sharp & Dohme (MSD, NYSE: MRK), Johnson & Johnson (J&J, NYSE: JNJ), BeiGene…
-
Danaher Corporation Reports Q3 2023 Earnings with 10.5% Global Revenue Decline
•
US-based science and tech services giant Danaher Corporation (NYSE: DHR) has reported its Q3 2023 earnings, with global revenues experiencing a 10.5% year-on-year (YOY) decline to USD 6.9 billion, resulting in net earnings of USD 1.1 billion. CEO Rainer M. Blair highlighted that revenues surpassed forecasts, driven by increased respiratory…
-
Danaher Partners with Beijing’s Changping District to Accelerate Science and Technology Innovation Center
•
US-headquartered Danaher (NYSE: DHR), a Fortune 500 science and technology innovator, has entered into a partnership with the Changping District People’s Government of Beijing Municipality. The collaboration aims to jointly accelerate the construction of Danaher’s science and technology innovation center in the North and a leading synthetic biology innovation service…
